Janine Marie Traulsen

CV

EDUCATION

1991 Fil.dr. (Sociology) The University of Lund, Sweden

1980 B.A. (Sociology) Goddard College, Vermont, USA

EMPLOYMENT

• 2016 - Present External Lecturer, Section for Social & Clinical Pharmacy, Department of Pharmacy, Faculty of Health & Medical Sciences, University of Copenhagen 
• 1996 – 2016. Associate Professor, Section for Social & Clinical Pharmacy, Department of Pharmacy, Faculty of Health & Medical Sciences, University of Copenhagen.
• 2005 Member of Multi-disciplinary Research Team – on contract for WHO in Kiev
• 2002 Member of Multi-disciplinary Research Team - Euro Health Group on contract for WHO
• 2000 Member of Multi-disciplinary Research Team – on contract in Tanzania for DANIDA
• 1988-1996 Assistant Professor/Research Associate, The Royal Danish School of Pharmacy
• 1991-1995 External Lecturer/Research Associate. Institute for Technology and Society. DTU
•  1985-1988 Project Leader “Family Planning Service Delivery in Denmark”. Medical Faculty, University of Copenhagen. Financed by Office of Population Affairs, Dept. Health & Human Services, Washington, D.C
• 1982-1987 Scientific Consultant (fulltime position). World Health Organization European Regional fice, Copenhagen. a) 1982-85 Health Education Unit (Health Promotion) b) 1985-87 Global Program for Appropriate Health Care Technology Tasks included: coordination of research activities; administrative responsibility for international meetings; communicating the work and program of the WHO to international audiences  

RESEARCH EXPERIENCE

Over 25 years of research experience. Main areas of research include: medical sociology; pharmaceutical policy; the pharmacy profession; medical technology assessment; fertility – including several studies on abortion and repeat abortion. Over 15 years’ experience with pharmaceutical policy and evaluation research including several projects analyzing the effects of the liberalization/deregulation of the pharmacy sector in Iceland and Denmark.  Author/co-author of four books. Have published over 90 scientific articles and numerous chapters in books and hundreds of articles in popular format.

TEACHING EXPERIENCE

Over 25 years of teaching experience within the curricula for social science and medicine (social pharmacy) on the undergraduate, Master’s and Ph.d. level. Main topics: pharmaceutical policy; medical sociology; research methods & research theories in social sciences; Medical Technology Assessment. Member of the study board & curriculum committees  Danish Pharmaceutical Univ- 1990’s. Active in the implementation of the Master of Drug Management program, member of Pharma Study Board since 1999. Supervisor for over 10 Ph.d. students; opponent on numerous Ph.d. dissertations (in Denmark, Sweden Finland); member of the review committee for various academic positions.

MEMBERSHIP IN COMMITTEES AND BOARDS

• Member Editorial Board - Pharmacy - 2018-2020
• Member Editorial Board - International Journal of Pharmacy Practice 2012-present
• Member of the Scientific Committee - 9th Nordic Social Pharmacy & Health Services Research Conference, 2019
• Member of the Scientific Committee – International Social Pharmacy Workshop 2014
• Member of LSU, Department of Pharmacy 2012-present • Member of Uddannelsesrådet for PharmaSchool 2012-present • Member of Uddannelsesledelsekredsen, SUND/KU 2012-present
• Scientific Advisory Board: Research Institute for Pharmaceutical Outcomes and Policy, University of Iceland. 2007- present. • Head of the Masters in Drug Management Education 2010-present.
• Member of the Study Board, Master’s Program School of Pharmaceutical Sciences 1999-present • Member of Stipendieudvalget, FARMA 1996 - 2012
• Member of the working group for the project”Test yourself”, Danish Board of Technology 2010- 2011
• Assessment Committee for Professor of social science. Norsk Center for Elektronisk Patientjournal 2005
• Steering Group 2nd and 3rd Nordic Social Pharmacy and Health Services Research Conferences, .Finland 2005 Copenhagen 2007
• Peer reviewer: Pharmacy World and Science; International Journal of Pharmacy Practice
• Appointed Member: Scientific Committee 14th International Social Pharmacy Workshop. Oxford, July, 2006.

The following is a selection of projects for which I have been advisor.

Main Supervisor – Ph.d. projects:

• 2000 Risk of future Drugs – expert & citizen perspectives
• 2004 Drug distribution in Denmark – in light of deregulation
• 2008 Management and organization in Danish Pharmacies
• 2012 Patients as consumers – A qualitative study on lay perspectives on the medical management of atopic dermatitis
• Current Medicine use for non-disease conditions among young persons.
• Current Counterfeit medicines – falsified medicines and European consumers
• Co-supervisor – numerous Ph.d. projects (selected titles)
• 2009 Analysis of local organizational measures important for lasting implementation of the first publicly reimbursed pharmacy service "check inhalation" – an explorative case study of seven Danish pharmacies
• 2013 Encounters with medicines among ethnic minorities with chronic conditions: Perspectives from policy, professionals and patients
• 2016. Fighting for Patient Safety: A qualitative case study on the role of private stakeholders and national authorities in the making of the EU Falsified Medicines Directive

Main Supervisor – numerous masters projects: (selected titles dealing with pharmaceutical policy)

• 2009 Cross-border healthcare at the pharmacy –a case study concerning the Eu’s influence on Danish community pharmacies
• 2010 Counterfeit medicines – a case study of Denmark
• 2013 The future of the Danish drug distribution system 2013 Market Access for new hospital drugs in the context of the economic crisis
• 2016 Falsified Medicines Directive

PUBLICATIONS 

Books

Morgall, J. Technology Assessment. Philadelphia. Temple University Press. 1993

Bissell P, Traulsen JM. Sociology and Pharmacy Practice. (300 pages): London, Pharmaceutical Press. 2005.

Chapters in Books

• Kaae S, Traulsen JM. Qualitative Methods in Pharmacy Practice Research. Chapter 4 in Zaheer-Ud-Din Babar (Ed.) Pharmacy Practice Research Methods. New York, Adis - Springer. 2015.
• Traulsen, JM, Britten N. Krska J. Determinants of drug utilization - the patient perspective. Chapter 2.5.3 in Drug utilization Research: Methods and Applications. John Wiley & Sons Ltd. 2015
• Traulsen, JM, Bissell, P. Health Disparities: International perspectives. Chapter 4 in Social and Behavioral Aspects of Pharmaceutical Care 2nd Edition. Nathaniel Rickles, Albert Wertheimer & Mickey Smith (editors). Jones and Bartlett Publishers, Boston. 2010. pp 61-73.
• Rickles, NM, Britten, N, Traulsen, JM and Bissell, P. Patient Decision Making: responses to illness and treatment. Chapter 10 in: Social and Behavioral Aspects of Pharmaceutical Care 2nd Edition. Nathaniel Rickles, Albert Wertheimer & Mickey Smith (editors). Jones and Bartlett Publishers, Boston. 2010.pp 177-194.
• Almarsdóttir AB, Traulsen JM, Björnsdóttir I. Lay views on Pharmacogenomics and Future Drug Development. Chapter in: Technology in Society. University of Iceland. 2005;287-304.
• Almarsdóttir AB, Traulsen JM, Björnsdóttir I. “We don’t have that many secrets “– the lay perspective on privacy and genetic data.  Chapter 22 in: Blood and Data – ethical, legal and social aspects of human genetic databases. Gardar Árnason, Salvör Nordal and Viljálmur Árnason (Editors).  University of Iceland. 2004. ISBN: 9979-54-593-3.  
• Morgall Traulsen, J, Björnsdóttir I. Confidentiality – an issue for whom? Focus group interviews with the lay public in Iceland. In the conference proceedings: Innovations for an e-Society. Challenges for Technology Assessment. Edited by Institut für Technik-folgenabschätzung und Systemanalyse. Federal Ministry of Education and Research. 2001. ISBN: 3-89750-097-3.
• Timm H, Hansen HP, Morgall JM, Sigmund H. Patienten – feltarbejde, interview- og spørgeskemaundersøgelser [The patient - field work, interview and questionnaire studies (DK + GB)]. In: Kristensen FB, Hørder M, Poulsen PB, editors. Metodehånd¬bog for Medicinsk Teknologivurdering [Methodology manual for medical technology assessment (Two versions Danish and English). Copenhagen: Centre for Evaluation and Health Technology Assessment; 2001. p. 36-55.

Scientific Articles - Peer Reviewed

1. Traulsen JM, Druedahl LC. Shifting perspectives - planning for the future of the pharmacy profession. Research in Social and Administrative Pharmacy. 2018.
2. Piatkiewicz TJ, Traulsen JM, Holm-Larsen T. Risk-sharing agreements in the EU: a systematic review of major trends. PharmacoEconomics Open. July 2017. DOI 10 1007/s41669-017-0044-1. 15 pages.
3. Arevalo LC; Traulsen JM; Nørgaard LS. Addressing Ethnic Inequalities in Medicine use in Denmark: selected theory-based interventions. Public Health Panarama, Bind 2, Nr. 4, 12.2017, s 477-493.
4. Lind JLM; Kaae S; Genina N; Rantanen J; Traulsen JM; Kälvemark SS. Printing medicine: new technique and its impact on society. Abstract from Nordic Social Pharmacy and Health Services Research Conference 2017, Juopio, Finland.
5. Lau SR; Traulsen JM. Are we ready to accept the challenge? Addressing the shortcomings of contemporary qualitative health research. Research in Social and Administrative Pharmacy, Bind 13, Nr. 2, 03.2017, s 332-338.
6. Mygind A; Nørgaard LS; Traulsen JM; El-Souri M; Kristiansen M. Drawing on healthcare professionals' ethnicity: lessons learned from a Danish community pharmacy intervention for ethnic minorities. Scandinavian Journal of Public Health, Bind 45, Nr. 3, 2017, s. 238-243.
7. Traulsen JM; Druedahl LC; Kälvemark SS; Careers, Professions & the organization of work in contemporary society - what does it mean for pharmacists? Research in Social and Administrative Pharmacy. Bind 13(3), 2017, s.e14-15.
8. Vestergaard SK; Nørgaard LS; Traulsen JM; Kaae S. The shaping of a profession: Pharmacy Internship Student's role perceptions compared to those of their supervisors and the customers. American Journal of Pharmaceutical Education, Bind 81/1, 2017.
9. Borup R; Traulsen JM. Falsified Medicines - bridging the gap between business and public health. Pharmacy, Bind 4 Nr. 2, 28.03.2016
10. Borup R; Kaae S; Minssen T; Traulsen JM. Fighting falsified medicines with paperwork - a historic review of Danish legislation governing distribution of medicines. Journal of Pharmaceutical Policy and Practice, Bind 30, Nr. 9, 06.10.2016, s.1-8.
11. Avevalo LC; Traulsen JM; Nørgaard LS. ПРЕОДОЛЕНИЕ ЭТНИЧЕСКОГО НЕРАВЕНСТВА В ПОТРЕБЛЕНИИ ЛЕКАРСТВЕННЫХ СРЕДСТВ В ДАНИИ: ВЫБРАННЫЕ ТЕОРЕТИЧЕСКИ ОБОСНОВАННЫЕ ВМЕШАТЕЛЬСТВА: Adressing ethnic inequalities in medicine use in Denmark. Public Health Panorama, Bind 2, Nr. 4, 2016, s. 494-513.
12. Kaae S; Sporrong SK; Traulsen JM: Wallach KH; Nørgaard LS. LC; Traulsen JM; Nørgaard LS. Experiences from a pilot study on how to conduct a qualitative multi-country research project regarding use of antibiotics in Southeast Europe.Journal of Pharmaceutical Policy and Practice, Bind 9, 20, 2016.
13. Sporrong SK; Traulsen JM: Woynabeba D; Bitsatab MH; Teshome GD; Essah NA; Khan SA; Brown AN:  ng SK; Traulsen JM;Wallach KH;Nørgaard LS;et.al Experiences from a pilot study on how to conduct a qualitative multi-country research project regarding use of antibiotics in Southeast Europe.Journal of Pharmaceutical Policy and Practice, Bind 9, 20, 2016.
14. Nørgaard LS; Rasmussen AM; Kristiansen M; Traulsen JM. Involving pharmacists with ethnic minority background as professional peers in pharmacy-based interventions:lessons learned from an extended medication review intervention tailored to ethnic minority poly-pharmacy patients in Denmark.  International Journal of Pharmacy Practice, Bind 24 , Nr. S2, 2016, s. 49-49.
15. Petersen MA;Brix M; Traulsen JM; Nørgaard LS. Universitgy student's use of study drugs: focus on taboos, knowledge and intentions. International Journal of Pharmacy Practice, Bind 2016, Nr. 2, 2016, s. 23.
16. Nørgaard LS;Kaae S; Traulsen JM. Different perceptions of pharmacy/pharmacist role: a case from Danish pharmacy internship. International Journal of Clinical Pharmacy, Bind 37, Nr. 1, CP-PC002, 2015, s. 180-180
17. Nørgaard LS; Traulsen JM; Mygind A; Espersen S. Encounters with immigrant customers: perspectives of Danish community pharmacy staff on challenges and solutions. International Journal of Clinical Pharmacy, Bind 37, Nr. 1, DI003, 2015, s. 260-260.
18. Petersen MA, Nørregaard LS, Traulsen JM.. Going to the doctor with enhancement in mind – an ethnographic study of University Students’ use of prescription stimulants and their moral ambivalence. Drug, Education, Prevention and Policy. 2015. DOI: 10.3109/09687637.2014.970517.
19. Petersen MA;Nørgaard LS; Traulsen, JM. Pursuing Pleasures of Productivity:University Students'Use of Presecription Stimulants for Enhancement and the Moral Uncertainty of Making Work fun. Culture, Medicine and Psychiatry, Bind 39, Nr. 4, 2015, s. 665-679. Forskning - fagfællebedømt › Tidsskriftartikel
20. Kaae S; Nørgaard LS; Traulsen JM. Different perceptions of pharmacy/pharmacist role: a case from Danish pharmacy internship. Research in Social and Administrative Pharmacy, Bind 10, Nr. 5, 2014, s. e19-e19
21. Sankaranarayanan, A; Traulsen, JM;Kälvemark Sporrong S; Human resource development in supply chain management - what do the UN agencies say? Brown, Andrew.Pharmaceutical Policy & Practice, Bind 7, Nr. Suppl 1, 2014, s. P7. Konferenceabstrakt
22. Traulsen JM; Petersen MA; Nørgaad LS. University student's views on the self-prescribing of "study drugs". Research in Social and Administrative Pharmacy, Bind 10, Nr. 5, 2014, s. e58-e59.
23. Cantarero-Arevalo L, Kassem D, Traulsen JM.  A culturally competent education program to increase understanding about medicines among ethnic minorities. Int J Clin Pharm 2014.
24. Almarsdóttir AB, Kaae S, Traulsen JM. Opportunities and challenges in social pharmacy and pharmacy practice research. Research in Social & Administrative Pharmacy. 2013 in press.
25. Kaae S, Traulsen JM, Nørgaard LS. Challenges to counseling customers at the pharmacy counter – why do they exist? Research in Social & Administrative Pharmacy, 8 (2012)  253-7.
26. Mygind A, Espersen S, Nørgaard LS, Traulsen JM Encounters with immigrant customers: Perspectives of Danish community pharmacy staff on challenges and solutions. International Journal of Pharmacy Practice, 2012 Sep 21. Doi:10.1111/j.2042-7174.2012.00237.x 
27. Kaae S  Traulsen JM Nørgaard LS. Customer interest in and experience with various types of pharmacy counseling  – a qualitative study.  Health Expectations, 2012.Oct 1.doi:10.1111/hex.12003..
28. Mygind A, Traulsen JM, Nørgaard LS, Bissel P. The ambiguity of ethnicity as risk factor of vitamin D deficiency – A case study of Danish vitamin D policy documents. Health Policy 2011;102:56-63. DOI:10.1016/j.healthpol.2011.05.012.
29. Mygind A, Traulsen JM, Nørgaard LS, Bissel P. The ambiguity of ethnicity as risk factor of vitamin D deficiency – A case study of Danish vitamin D policy documents. Health Policy 2011;102:56-63. DOI:10.1016/j.healthpol.2011.05.012.
30. Kaae S, Søndergaard B, Haugbølle LS, Traulsen JM. The relationship between leadership style and provision of the first Danish publicly reimbursed cognitive pharmaceutical service—A qualitative multicase study. Research in Social and Administrative Pharmacy 2011;7:113-121.
31. Kaae S, Søndergaard B, Haugbølle LS, Traulsen JM. Development of a qualitative exploratory case study research method to explore sustained delivery of cognitive services. Pharmacy World & Science 2010;32:36-42. DOI:10.1007/s11096-009-9337-5.
32. Kaae S, Søndergaard B, Stig L; Traulsen JM. Sustaining delivery of the first publicly reimbursed cognitive service in Denmark: a cross-case analysis . International Journal of Pharmacy Practice.Volume 18, Issue 1, pages 21–27, February 2010
33. Nørreslet M, Bissel P, Traulsen JM. From consumerism to active dependence: Patterns of medicines use and treatment decisions among patients with atopic dermatitis. Health 2010;14:91-106. DOI:10.1177/1363459309347648      
34. Noerreslet M, Jemec GBE, Traulsen JM. Involuntary autonomy: Patients’ perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis. Social Science & Medicine 2009;69;1409-1415. DOI:10.1016/j.socscimed.2009.08.036
35. Björnsdóttir I, Almarsdóttir AB, Traulsen JM. The lay public's explicit and implicit definitions of drugs. Research in Social and Administrative Pharmacy 2009;5:40-50. DOI:10.1016/j.sapharm.2008.04.003.
36. Almarsdóttir AB, Traulsen JM. Multimethod research into policy changes in the pharmacy sector—the Nordic case. Research in Social and Administrative Pharmacy 2009;5:82-90. DOI:10.1016/j.sapharm.2008.04.005.
37. Björnsdóttir I, Almarsdóttir AB, Traulsen JM. The lay public's explicit and implicit definitions of drugs. Research in Social and Administrative Pharmacy 2009;5:40-50. DOI:10.1016/j.sapharm.2008.04.003.
38. Almarsdóttir AB, Traulsen JM. Multimethod research into policy changes in the pharmacy sector—the Nordic case. Research in Social and Administrative Pharmacy 2009;5:82-90. DOI:10.1016/j.sapharm.2008.04.005.
39. Kaae S, Traulsen JM, Søndergaard B, Haugbølle LS. The relevance of political prestudies for implementation studies of cognitive services in community pharmacies. Research in Social and Administrative Pharmacy 2009;5:189-194. DOI:10.1016/j.sapharm.2008.06.001.
40. Traulsen JM, Björnsdóttir I, Almarsdóttir AB. ‘I’m happy if I can help’. Public views on future medicines and gene-based therapy in Iceland. Community Genetics 2008;11:2-10. DOI:10.1159/000111634.
41. Ryan K, Bissell P, Anderson C, Traulsen JM, Sleath B. Teaching social sciences to undergraduate pharmacy students: an international survey. Pharmacy Education, March 2007;7(1): 1-9.
42. Larsen JB, Vrangbæk, K, and Traulsen JM. Advocacy coalitions and pharmacy policy in Denmark – Solid cores with fuzzy edges.  Social Science & Medicine (63):212-224, 2006.
43. Almarsdóttir A B, Traulsen J M. 2006. Studying and evaluating pharmaceutical policy –becoming a part of the policy and consultative process.  Pharm World Sci 28:6-12, 2006.
44. Björnsdóttir I,  Almarsdóttir AB,  Traulsen JM. 2006.  Definitions of drugs: the less conscious issues. The International Journal of Pharmacy Practice 2006. Vol 14, supplement 1:A31.
45. Traulsen JM, Almarsdóttir AB. Pharmaceutical policy and the pharmacy profession. Pharm World Sci. 2005:27:359-363.
46. Traulsen JM and Almarsdóttir AB. Pharmaceutical policy and the lay public. Pharm World Sci 27:273-277, 2005.
47. Rossing C, Hansen EH, Traulsen JM, and Krass I. Actual and perceived provision of phamaceutical care in Danish community pharmacies: the phamacists' opinions. Pharm World Sci (27):175-181, 2005.
48. Nørreslet M, Larsen JB, and Traulsen JM. The medicine user - Lost in translation? Analysis of the official political debate prior to the deregulation of the Danish medicine distribution system. Social Science & Medicine (61):1733-1740, 2005.
49. Almarsdóttir AB, Björnsdóttir I, and Traulsen JM. Lay views on Pharmacogenomics and Future Drug Development. In: Technology in Society - Society in Technology, University of Iceland Press, 2005, p. 287-304.
50. Almarsdóttir AB and Traulsen JM. Cost-containment as part of phamaceutical policy. Pharm World Sci (27):144-148, 2005.
51. Almarsdóttir AB, Björnsdóttir I, and Traulsen JM. A lay prescription for tailor-made drugs-focus group reflections on pharmacogenomics. Health Policy 71:233-241, 2005.
52. Almarsdóttir AB and Traulsen JM. Rational use of medicine - an important issue in pharmaceutical policy. Pharm World Sci (27):76-80, 2005.
53. Møldrup C, Knudsen P, and Traulsen JM. Betegnelsen lykkepiller er et dansk og problematisk fænomen. Ugeskrift for Læger (21):2282-2285, 2005.   
54. Traulsen JM and Almarsdóttir AB. Editorial. Pharm World Sci 27:1, 2005.
55. Traulsen JM and Almarsdóttir AB. The argument for pharmaceutical policy. Pharm World Sci 27:7-13, 2005.
56. Almarsdottir AB, Traulsen JM, Björnsdottir I. "We don't have that many secrets" - the lay perspective on privacy and genetic data. In: Arnason G, Nordal S, Arnason V, editors. Blood & Data - Ethical, Legal and Social Aspects of Human Genetic Databases. Reykjavik: University of Iceland Press & Centre for Ethics, 2004: 195-202.
57. Almarsdottir AB, Björnsdottir I, Traulsen JM. A lay prescription for tailor-made drugs-focus group reflections on pharmacogenomics. Health Policy 2004; 71:233-241.  
58. Bissell P, Traulsen JM. Concluding comments. International Journal of Pharmacy Practice 2004; 12:169-171.  
59. Larsen JB, Traulsen JM, Kruse PR. Forskning i liberalisering af apotekervæsenet i Danmark. Theriaca 2004; 34(1):113-125.
60. Ryan K, Bissell P, Traulsen JM. The work of Michel Foucault: relevance to pharmacy practice. International Journal of Pharmacy Practice 2004; 12:43-52.  
61. Traulsen JM, Klinke BO. Using health technology assessment to put pharmaceutical care on the political agenda. Pharmacy World & Science 2004; 26:61-63.  
62. Traulsen JM, Bissell P. (9) Theories of professions and the pharmacist. International Journal of Pharmacy Practice 2004; 12:107-114.  
63. Traulsen JM, Almarsdottir AB, Björnsdottir I. Interviewing the Moderator: An ancillary Method to Focus Groups. Qualitative Health Research 2004; 14(5):714-725.
64.  Traulsen JM, Nørreslet M. The new consumer of medicine - the pharmacy technicians' perspective. Pharmacy World & Science 2004; 26:203-207.
65. Bissell P, Traulsen JM, Haugbølle LS. (6) Researching "race", ethnicity and health: a critical review. International Journal of Pharmacy Practice 2003; 11:183-197.
66. Møldrup C, Traulsen JM, Almarsdóttir AB. Medically-enhanced normality: an alternative perspective on the use of medicines for non-medical purposes. International Journal of Pharmacy Practice 2003; 11:243-249.
67. Møldrup C, Traulsen JM, Peck JC. Methodological development in medical technology assessment: the prospective approach. International Journal of Risk Research 2003; 6(2):95-112.
68. Rossing C, Hansen EH, Krass I, Traulsen JM. Pharmaceutical care in Denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharmacy World & Science 2003; 25(2):73-78.
69. Traulsen JM, Bissell P. (7) The risk society. International Journal of Pharmacy Practice 2003; 11:251-258.
70. Larsen JB, Traulsen JM, Kruse PR. Forskning I liberalisering af apotekervæsenet I Danmark. [Research in the liberalisation of the pharmacy in Denmark – an argument for greater emphasis on the history of pharmacy (Danish)]. Bibl Læger 2003; 195:117-29.
71. Traulsen JM, Bissell P, Haugbølle LS. Feminist theory and pharmacy practice. Int J Pharm Pract. 2003:11:55-68.
72. Traulsen JM, Almarsdóttir AB, Björnsdóttir I. The lay user perspective on the quality of pharmaceuticals, drug therapy and pharmacy services. Pharm World Sci 2002,24:5:196-200.
73. Knudsen P, Hansen EH, Traulsen JM. Perceptions of young women using SSRI antidepressants – a reclassification of stigma. Int J Pharm Pract. 2002:10:243-52.
74. Knudsen P, Hansen EH, Traulsen JM, Eskildsen, K: Changes in self-concept using SSRI antidepressants. Qualitative Health Research 2002:12:7:932-944.
75. Bissell P, Traulsen JM, Haugbølle LS. The contribution of interactionist sociology to understanding the experience of health and illness. Int J Pharm Pract. 2002:10:213-24.
76. Bissell P, Traulsen JM, Haugbølle LS, How relevant is Marxist sociology for pharmacy practice? Int J Pharm Pract. 2002:10:127-40.
77. Almarsdóttir, AB, Björnsdóttir, I, Morgall Traulsen JM. Pharmacists in a liberalised system – results from a profession-wide survey in Iceland. Int  J Pharm Pract 2002:10:47-53.
78. Møldrup C, Morgall JM, Almarsdóttir AB. Perceived risk of future drugs – a Danish citizen Delphi. Health Risk & Society 2002:4:1:5-17.
79. Bissell P, Traulsen JM, Haugbølle LS, An introduction to functionalist sociology: Talcott Parsons’ concept of the “sick role”. Int  J Pharm Pract 2002:10:60-8.
80. Bissell P, Haugbølle LS, Traulsen JM: The relevance of sociological theory to pharmacy practice research. Int J Pharm Pract 2001:9:289-295.
81. Møldrup C, Morgall JM. Risk Society Reconsidered in a Drug Context – the emergence of medically enhanced normality:  Health, Risk & Society 2001;3:59-74.
82. Møldrup C, Morgall JM. Risks of Future Drugs – a Danish expert delphi study: Technological Forecasting and Social Change 2001; 67:273-89.
83. Almarsdóttir AB , Morgall JM, Grimsson A. Professional Responsibility for the Patient’s Welfare - is it possible to legislate pharmaceutical care? J Soc Adm Pharm 2001;18:45-50.
84. Møldrup C, Morgall JM, Almarsdóttir AB. Citizen involvement in future drug R&D - a Danish delphi study. Foresight 2000;2:453-62.
85. AlmarsdóttirAB, Morgall JM, Grímsson A. Cost containment of pharmaceutical use in Iceland: the impact of liberalisation and user charges. J Health Serv Res Policy 2000;5:109-13.
86. Almarsdóttir AB, Morgall JM, Björnsdóttir I. A question of emphasis: efficiency or equality in the provision of pharmaceuticals. Int J Health Plann Mgmt 2000;15:149-61.
87. Nørgaard LS, Morgall JM, Bissell P. Arguments for theory-based pharmacy practice research. Int J Pharm Pract 2000;8:77-81.
88. Nørgaard LS, Sørensen EW, Morgall JM. Social constructivist analysis of a patient medication record experiment – why a good idea and good intentions are not enough. Int J Pharm Pract 2000;8:237-46.
89. Nørgaard LS, Morgall JM. The Social Construction of a Drug Interaction Screening Program – expectations and change in Danish pharmacy practice. J Soc Adm Pharm 2000;17:110-117. ISSN: 0281-0662
90. Morgall JM,  Almarsdóttir AB. No struggle, no strength: how pharmacists lost their monopoly. Soc Sci Med 1999;48:1247-58.
91. Almarsdóttir AB, Morgall JM. Technicians or patient advocates? – still a valid question (results of focus group discussion with pharmacists). Pharm World Sci 1999; 21:127-31.
92. Morgall JM, Almarsdóttir AB. The New Consumer – implications for pharmacy. Int J Pharm Pract 1999;7:198-201.
93. Møldrup C, Nørgaard LS, Morgall JM. Medicinsk teknologivurdering i praksis [Assessment of medical technology in practice (Danish)]. Ugeskr Laeger 1998;160(47):6836-7.
94. Osler M, David HP, Morgall JM. Multiple induced abortions: Danish experience. Patient Educ Couns 1997;31:83-9.
95. Morgall, JM. Medical Technology Assessment: a useful occupation or useless diversion? Women's Studies International Forum 1993,16:591-604.
96. Morgall JM. Gentagne aborter - erfaringer fra samtaler [Repeat Abortions - interview experience (Danish)]. Månedsskrift for praktisk lægegerning October 1993:865-9.
97. Osler M. Morgall JM, Jensen B. Repeat abortion in Denmark. Dan Med Bull 1992; 39:89-91.
98. Morgall JM. Gentagne aborter – erfaringer fra samtaler – hvad kan der gøres for at undgå “recidiv” . (In Danish). Månedsskr Prakt Lægegern. Oktober 1993. 865-869.
99. David HP, Morgall JM. Family Planning for the Mentally Disordered and Retarded. The Journal of Nervous and Mental Disease,1990:176 (6).
100. Osler M, David HP, Morgall JM, Rasmussen NK. Family planning services delivery. Dan Med Bull 1990:37:95-105.
101. Rasmussen NK, Morgall JM. The use of alternative treatments in Danish adult population. Complementary Medical Research. May 1990. 4(2) 16-22.
102. David HP, Morgall JM, Osler M, Rasmussen NK, Jensen B. United States and Denmark: Different Approaches to Health Care and Family Planning. Studies in Family Planning, Vol. 21, No. 1 (Jan. - Feb., 1990), pp. 1-19.
103. Morgall JM, Sørensen EW. International health and drug distribution annual course for pharmacists Copenhagen Denmark. Journal of Social and Administrative Pharmacy,1990  7 (3). 141-143.
104. Koch L, Morgall JM. Towards a Feminist Assessment of Reproductive Technology.  Acta Sociologica 1987 Vol 30 issue: 2, page(s): 173-191. Issue published: April 1, 1987.https://doi.org/10.1177/000169938703000204 
105. Morgall JM, Vedel G.  Office Automation. Economic and Industrial Democracy 1985; Volume: 6 issue: 1, page(s): 93-112. Issue published: Feb 1, 1985. https://doi.org/10.1177/0143831X8561005.
106. Morgall JM. New Office Technology.  Typing our way to freedom Is it true that new office technology can liberate women?,Behaviour & Information Technology, 1983, 2:3, 215-226, DOI: 10.1080/01449298308914478.  

Other publications

• Borup R, Traulsen JM. Counterfeit – Københavns universitet forsker i forfalskede lægemidler. Pharma – maj 2013 side 26-27.
• Petersen MA, Laing E, Traulsen JM. What are university students’ views on the self-prescribing of ”smart drugs”?. The Pharmaceutical Journal, vol 289 2012.
• Petersen MA, Vestergaard S, Traulsen JM. Når medicin bliver hverdagskost. Pharma – august 2012 side 34-35.   Teknologi-rådet. Test dig selv! – vurderinger og anbefalinger vedrørende anvendelse af medicinsk udsyr til selvtestning.  Rapport fra projektet ”test dig selv”.  (Test yourself! – evaluation and recommendations of use of medical equipment for self-testing.  Report from the project "test yourself ). Member of working group. 2011. (45 pages). In Danish.  ISBN: 87-91614-60-0.
• Traulsen JM, Klinke BO. Projekt Håndbogen – praktisk arbejde med projekter og interventioner indenfor lægemiddelområdet. The Danish University of Pharmaceutical Sciences. 2005. (27 pages). (In Danish). ISBN 87-990703-0-8
• Almarsdóttir AB, Traulsen JM. Exploring the interface between research and action – a pilot project of the local research community and the WHO in Ukraine. A WHO/EURO Report. December 2005 (30 pages). Restricted access (for internal distribution only).
• Traulsen JM, Klinke BO. Project Handbook – from idea to project – a handbook for pharmacy projects. The Danish University of Pharmaceutical Sciences. 2005. (27 pages). (English).  ISBN 87-990703-1-6.
• Nørreslet M, Traulsen JM. Den aktive, engagerede og usikre lægemiddelforbruger. Lægemiddelforskning, 2005. 38-39.
• I. Björnsdóttir,A.B. Almarsdóttir, J.M. Traulsen Focus Group Discussions as a method for public health research.  The 8th Nordic Public Health Conference, Reykjavík, October 9-11, 2005  Abstr. no.: 23 (Poster).
• I. Björnsdóttir,A.B. Almarsdóttir, J.M. Traulsen the Lay Public’s definitions of drugs in Iceland. The th FIP World Congress of Pharmacy and Pharmaceutical Scieinces 2005. 65th Congress. 2-8 September 2005, Cairo Abstr. no.: CPS-P.084(Poster).
• Traulsen JM. Health Technology Assessment and Pharmaceutical Care. Pharmaceutical Care Network Europe. 3rd International Working Conference – Pharmaceutical Care Research – the next generation.  Conference Proceedings. 2004;25-32. (www.pcne.org)
• Klinke BO, Traulsen JM. BUZZWORDS – Prince 2. Farmaceuten, 17, 2004:7.
• Klinke BO, Traulsen JM. BUZZWORDS – Bottom-up-economy. Farmaceuten, 13, 2004:9.
• Klinke BO, Traulsen JM. BUZZWORDS – En vifte af buzzwords. Farmaceuten, 11, 2004:8.
• Traulsen JM, Klinke BO. BUZZWORDS – Hvad er Medicinsk Teknologi Vurdering – MTV? Farmaceuten, 7, 2004.
• Traulsen JM, Klinke BO. BUZZWORDS – Den Lærende Organisation. Farmaceuten, 6, 2004;9.
• Traulsen JM, Klinke BO. BUZZWORDS – Corporate Story Telling. Farmaceuten, 5, 2004; 10-11.
• Larsen JB, Traulsen JM. Liberaliseringen, der blev væk. Lægemiddelforskning, 2003:36-37.
• Traulsen JM, Björnsdóttir I. Confidentiality – an issue for whom? – results of focus group interviews. Journal of Social and Administrative Pharmacy, 19;(6)2002:215.
• Traulsen JM, Björnsdóttir I, Almarsdóttir A. What do the public want? A study of the hopes and fears of the lay public for the future of medicine. ZOOM - FIP- Community Pharmacy Section. November 2002:4-6.
• Björnsdóttir I, Traulsen JM. The public’s obligations and rights with regard to providing data for research. Pharmacoepidemiology and Drug Safety, 11:S214. 2002.
• Rossing C, Hansen EH, Morgall JM.Farmaceutisk omsorg på apotekerne. [Pharmaceutical Care in the Community Pharmacy (Danish)]. Lægemiddelforskning 2001: 38-9.
• Morgall JM. Teknologivurdering - medicinsk teknolo­givur­dering [Technology assessment - medical technology assessment (Swedish)]. MOTPOL - tidskrift för sjukvårdsdebatt 1992; (årgång 68) 637.
• Osler M, Morgall JM, Jensen B. Repeat Abortion: the Danish Experience. The Sexuality and Family Planning Unit, World Health Organization 1990.
• Morgall JM. Hvor er kvinderene henne i teknologidebatten. Kvinder 1981:44:543-546